Our Sponsors

Company profile

CellGenix is a leading global supplier of high quality raw materials for the expanding cell and gene therapy and regenerative medicine space.

We develop, manufacture and market human cytokines and growth factors in preclinical and GMP quality along with GMP serum-free media for further manufacturing of ATMPs. Our products are used by academia and industry partners in clinical trials and commercial manufacturing throughout the world.

With over 20 years of experience we are experts in the GMP manufacturing of raw materials for the cell and gene therapy space. As an ATMP developer and manufacturer we gained in-depth cell culture knowledge and superior regulatory expertise. With this unique background we understand the high requirements our customers face during product development and the regulatory approval process. By offering expert technical and regulatory support we can help simplify raw material qualification and validation efforts.


CellGenix is headquartered in Freiburg, Germany
and operates a subsidiary near Boston in Portsmouth, USA.


Become a member of the amc

Keep up to date with our latest events

  • Whilst the UK is excellent in scientific development of cell therapies, robust manufacturing processes, essential to establishing industry, now need to be developed.

    Lucy Foley amc
  • Developing best practice in cell therapy manufacturing

    ATMP Manufacturing Community amc
  • By building a critical mass we can share best practice and act as a voice to suppliers, regulators and industry to establish robust cell therapy manufacture.

    Angela Osborne amc
  • Our vision is that the whole ATMP Manufacturing Community is the team. Members are encouraged to attend, speak and facilitate our meetings, as well as being proactive in our online presence.


    Emily Culme-Seymour amc

We are always looking for new members of the team. If you are interested please get in touch. contact@atmpmanufacture.org

If you think you would like to help us with the running of the amc community we would love to hear from you.